Labeling: Label Mix-Up: Product is incorrectly labeled as phenylephrine 50 mg in 0.9% sodium chloride rather than phenylephrine 50 mg in 5% dextrose.
Prescription Drugs
π Drugs β’ 12,141 recalls
Hyaluronidase (RM ONLY), Injectable Solution, 150 U/mL, 10ML vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Subpotent Drug; out of specification results for heparin raw material
Alprostadil (PFE1), solution, 30 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only. Manufactured for: Teva Pharmaceuticals USA Sailorsville, PA 13960. Manufactured in Canada By: Valeant Pharmaceuticals International, Inc. Steinbach, MB R5G 127 Canada. NDC: 0093-2059-01.
Valeant Pharmaceuticals North America
Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.
Trimix (PGE1;PHENT;PAP) (N), injectable, (100/10/240) 10UG, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Alprostadil (PFE1), Solution, 10 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Trimix (A;PH,PA) (N), injectable, 160 UG-1.2 mg-9.6/ mg/mL, 2 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT.
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Labeling: incorrect or missing lot number and/or expiration date
Trimix (A;PH,PA) (N), injectable, 80 UG-0.6 mg-4.8 mg/mL, 1 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Glutathione INHALATION (PF), NASAL solution, 100 mg/mL, 3 mL vial, Rx only, dispensed by Montana Compounding Pharmacy, Missoula, MT
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Failed Impurities/Degradation Specifications
Avastin, solution, 1.25 mg/0.05mL, Injectable, Syringe, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Failed Impurities/Degradation Specifications
Trimix (PGE1;PHENT;PAP) (N), injectable, (100/10/297) 10UG, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Alprostadil (PFE1), solution, 20 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Montana Compounding Pharmacy
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point.
Failed Dissolution Specifications: OOS result during stability testing
Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids
Failed Dissolution Specifications: Low out of specification dissolution results.